We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CPIN:IDXPT Charoen Pokphand Indonesia Tbk Analysis

Data as of 2026-06-16 - not real-time

IDR 3,410.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

CPIN is trading at IDR 3,410, well under its 20‑day SMA of 3,877, 50‑day SMA of 4,091 and 200‑day SMA of 4,420, signaling a bearish technical backdrop. The RSI sits at 35.9, hinting at oversold conditions, while the MACD line remains negative and the histogram deepens, reinforcing short‑term downside pressure. Volatility is elevated at nearly 59% over the past month, though the beta of 0.30 suggests limited market‑wide correlation. Support sits around 3,080 and resistance near 4,520, with volume trending upward.
Fundamentally, the company posted 12.7% revenue growth, robust ROE of 19.5% and ROA of 12.8%, and a healthy operating margin of 17.2%. Cash balances exceed debt, and the dividend yield of 5.28% is backed by a modest 26% payout ratio, indicating sustainability. The DCF fair‑value estimate of roughly IDR 3,500 is marginally above the current price, while analyst targets average IDR 5,400, implying upside potential of over 50%. The consensus rating is "strong buy," reflecting confidence in the defensive farm‑products sector and the company’s cash‑generating capacity.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below key moving averages and bearish MACD
  • Strong dividend yield providing income cushion
  • Support level near IDR 3,080 offering downside protection

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervaluation relative to DCF and analyst price targets
  • Solid earnings growth and high ROE
  • Sustainable dividend payout supporting cash flow

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Defensive consumer‑defensive sector with stable demand
  • Consistent cash generation and net‑cash position
  • Long‑term upside potential reflected in strong analyst consensus

Key Metrics & Analysis

Financial Health

Revenue Growth12.70%
Profit Margin9.16%
P/E Ratio8.4
ROE19.50%
ROA12.82%
Debt/Equity18.07
P/B Ratio1.5
Op. Cash FlowIDR6612.9B
Free Cash FlowIDR2504.8B

Technical Analysis

TrendBearish
RSI35.9
SupportIDR 3,080.00
ResistanceIDR 4,520.00
MA 20IDR 3,877.00
MA 50IDR 4,091.20
MA 200IDR 4,419.88
MACDBearish
VolumeIncreasing
Fear & Greed Index93

Valuation

Fair ValueIDR 3,501.60
Target PriceIDR 5,400.00
Upside/Downside58.36%
GradeUndervalued
TypeBlend
Dividend Yield5.28%

Risk Assessment

Beta0.30
Volatility58.68%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.